Atea Pharmaceuticals Statistics
Total Valuation
AVIR has a market cap or net worth of $239.07 million. The enterprise value is -$86.46 million.
Important Dates
The last earnings date was Wednesday, November 12, 2025, after market close.
| Earnings Date | Nov 12, 2025 |
| Ex-Dividend Date | n/a |
Share Statistics
AVIR has 78.13 million shares outstanding. The number of shares has decreased by -1.09% in one year.
| Current Share Class | 78.13M |
| Shares Outstanding | 78.13M |
| Shares Change (YoY) | -1.09% |
| Shares Change (QoQ) | -5.61% |
| Owned by Insiders (%) | 14.85% |
| Owned by Institutions (%) | 59.92% |
| Float | 60.29M |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | n/a |
| PS Ratio | n/a |
| Forward PS | n/a |
| PB Ratio | 0.87 |
| P/TBV Ratio | 0.77 |
| P/FCF Ratio | n/a |
| P/OCF Ratio | n/a |
| PEG Ratio | n/a |
Financial Ratio History Enterprise Valuation
| EV / Earnings | n/a |
| EV / Sales | n/a |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | n/a |
Financial Position
The company has a current ratio of 16.66, with a Debt / Equity ratio of 0.00.
| Current Ratio | 16.66 |
| Quick Ratio | 16.32 |
| Debt / Equity | 0.00 |
| Debt / EBITDA | n/a |
| Debt / FCF | n/a |
| Interest Coverage | n/a |
Financial Efficiency
Return on equity (ROE) is -37.98% and return on invested capital (ROIC) is -25.60%.
| Return on Equity (ROE) | -37.98% |
| Return on Assets (ROA) | -23.86% |
| Return on Invested Capital (ROIC) | -25.60% |
| Return on Capital Employed (ROCE) | -49.32% |
| Revenue Per Employee | n/a |
| Profits Per Employee | -$2.63M |
| Employee Count | 56 |
| Asset Turnover | n/a |
| Inventory Turnover | n/a |
Taxes
In the past 12 months, AVIR has paid $831,000 in taxes.
| Income Tax | 831,000 |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has decreased by -10.51% in the last 52 weeks. The beta is 0.16, so AVIR's price volatility has been lower than the market average.
| Beta (5Y) | 0.16 |
| 52-Week Price Change | -10.51% |
| 50-Day Moving Average | 3.12 |
| 200-Day Moving Average | 3.17 |
| Relative Strength Index (RSI) | 38.74 |
| Average Volume (20 Days) | 401,032 |
Short Selling Information
The latest short interest is 6.40 million, so 8.20% of the outstanding shares have been sold short.
| Short Interest | 6.40M |
| Short Previous Month | 6.05M |
| Short % of Shares Out | 8.20% |
| Short % of Float | 10.62% |
| Short Ratio (days to cover) | 13.75 |
Income Statement
| Revenue | n/a |
| Gross Profit | -73.62M |
| Operating Income | -159.19M |
| Pretax Income | -146.19M |
| Net Income | -147.03M |
| EBITDA | -158.77M |
| EBIT | -159.19M |
| Earnings Per Share (EPS) | -$1.77 |
Full Income Statement Balance Sheet
The company has $329.31 million in cash and $1.05 million in debt, giving a net cash position of $328.26 million or $4.20 per share.
| Cash & Cash Equivalents | 329.31M |
| Total Debt | 1.05M |
| Net Cash | 328.26M |
| Net Cash Per Share | $4.20 |
| Equity (Book Value) | 315.78M |
| Book Value Per Share | 4.04 |
| Working Capital | 315.96M |
Full Balance Sheet Cash Flow
| Operating Cash Flow | -134.21M |
| Capital Expenditures | n/a |
| Free Cash Flow | -134.21M |
| FCF Per Share | -$1.72 |
Full Cash Flow Statement Margins
| Gross Margin | n/a |
| Operating Margin | n/a |
| Pretax Margin | n/a |
| Profit Margin | n/a |
| EBITDA Margin | n/a |
| EBIT Margin | n/a |
| FCF Margin | n/a |
Dividends & Yields
AVIR does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| Buyback Yield | 1.09% |
| Shareholder Yield | 1.09% |
| Earnings Yield | -60.80% |
| FCF Yield | -55.50% |
Analyst Forecast
The average price target for AVIR is $6.00, which is 96.08% higher than the current price. The consensus rating is "Hold".
| Price Target | $6.00 |
| Price Target Difference | 96.08% |
| Analyst Consensus | Hold |
| Analyst Count | 1 |
| Revenue Growth Forecast (5Y) | n/a |
| EPS Growth Forecast (5Y) | n/a |
Stock Forecasts Fair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| Lynch Fair Value | n/a |
| Lynch Upside | n/a |
| Graham Number | n/a |
| Graham Upside | n/a |
Stock Splits
This stock does not have any record of stock splits.
| Last Split Date | n/a |
| Split Type | n/a |
| Split Ratio | n/a |
Scores
| Altman Z-Score | n/a |
| Piotroski F-Score | 1 |